African-American inflammatory bowel disease in a Southern U.S. health center

Dept of Molecular & Cellular Physiology, 1501 Kings Highway, Shreveport, LA, 71130-3932, USA.
BMC Gastroenterology (Impact Factor: 2.37). 09/2010; 10(1):104. DOI: 10.1186/1471-230X-10-104
Source: PubMed


Inflammatory Bowel Diseases (IBD) remain significant health problems in the US and worldwide. IBD is most often associated with eastern European ancestry, and is less frequently reported in other populations of African origin e.g. African Americans ('AAs'). Whether AAs represent an important population with IBD in the US remains unclear since few studies have investigated IBD in communities with a majority representation of AA patients. The Louisiana State University Health Sciences Center in Shreveport (LSUHSC-S) is a tertiary care medical center, with a patient base composed of 58% AA and 39% Caucasian (W), ideal for evaluating racial (AA vs. W) as well and gender (M vs. F) influences on IBD.
In this retrospective study, we evaluated 951 visits to LSUHSC-S for IBD (between 2000 to 2008) using non-identified patient information based on ICD-9 medical record coding (Crohn's disease 'CD'-555.0- 555.9 and ulcerative colitis 'UC'-556.0-556.9).
Overall, there were more cases of CD seen than UC. UC and CD affected similar ratios of AA and Caucasian males (M) and females (F) with a rank order of WF > WM > AAF > AAM. Interestingly, in CD, we found that annual visits per person was the highest in AA M (10.7 ± 1.7); significantly higher (* -p < 0.05) than in WM (6.3 ± 1.0). Further, in CD, the female to male (F: M) ratio in AA was significantly higher (*- p < 0.05) (1.9 ± 0.2) than in Caucasians (F:M = 1.3 ± 0.1) suggesting a female dominance in AACD; no differences were seen in UC F: M ratios.
Although Caucasians still represent the greatest fraction of IBD (~64%), AAs with IBD made up >1/3 (36.4%) of annual IBD cases from 2000-2008 at LSUHSC-S. Further studies on genetic and environments risks for IBD risk in AAs are needed to understand differences in presentation and progression in AAs and other 'non-traditional' populations.

Download full-text


Available from: Ganta V Chaitanya
  • Source
    • "atypical Mycobacteria) [1]. Recent increases of IBD incidence in developing nations and nonclassical populations [2] also suggest socioeconomic status and environmental factors (e.g. dietary " hygiene " , and " cold chain " ) may contribute to IBD etiology [1]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Inappropriate responses to normal commensal bacteria trigger immune activation in both inflammatory bowel disease and experimental colitis. How gut flora contribute to the pathogenesis of inflammatory bowel disease is unclear, but may involve entrapment of leukocytes and remodeling of the vascular system. Here we evaluated how the progression and tissue remodeling in experimental colitis differ in a germ- free model of mouse colitis. Four treatment groups were used: control, antibiotic-treated (ABX), dextran sulfate colitis (DSS) and DSS pre- and co-treated with antibiotics (DSS + ABX). In days 0 - 3 of the study, germ-free mice received antibiotics (vancomycin, neomycin, and metronidazole). During the next 11 days, antibiotics were continued and DSS (3%) added to “colitis” groups. Disease activity, weight, stool form and blood were monitored daily. Mice were sacrificed and tissue samples harvested. Histopathological scores in controls (0.00) and in ABX (1.0+/–0.81) were significantly (p < 0.001) lower than DSS (12+/–0). Extents of injury, inflammation and crypt damage were all improved in DSS + ABX. The Disease Activity Index score (day 11) was significantly worse in the DSS group compared to the DSS + ABX group. Stool blood and form scores were also significantly improved among these groups. Importantly, myeloper- oxidase was significantly reduced in DSS + ABX, indicating that neutrophil infiltration was blocked. Colitis was associated with an increase in blood and lymphatic vessels; both of these events were also significantly reduced by gut sterilization. Our experiment shows that clinical and histopathological severity of colitis was significantly worse in the DSS colitis group compared to the DSS + ABX group, supporting the hypothesis that development of IBD is likely to be less severe with appropriate antibiotic treatment. In particular, gut sterilization effectively reduces leuko- cyte-dependent (PMN) injury to improve outcomes and may be an important target for therapy.
    Full-text · Article · Feb 2013 · Open Journal of Gastroenterology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Traditionally, inflammatory bowel disease has been a disease entity associated with European ancestry. Despite claims of rarity, numerous studies have emerged which indicate that the prevalence of IBD has increased in various ethnic groups worldwide. We illustrate that IBD is indeed a multi-ethnic disease and the clinical characteristics of IBD in our setting are presented in this study. Methods: A retrospective cross-sectional descriptive study of the medical records of IBD patients presenting to the Department of Gastroenterology, area 554 of the Charlotte Makexe Johannesburg Academic Hospital was undertaken. One hundred twenty-six patients with IBD referred to this tertiary gastrointestinal centre from 2005 through 2010, were assessed. Demographic and historical characteristics, clinical features as well as drug and surgical interventions were assessed according to a predetermined patient data collection form. Results: Analyses demonstrated that 63.5% of the sample had UC, 34.1% had CD and 2.4% were diagnosed as having IC, with a female to male ratio of 1.4: 1. There were comparable numbers of White, Indian and Black patients with UC but very few Black patients contributed to the CD burden. Moreover, CD was established as a more severe disease entity as manifest by a higher proportion of extra-intestinal manifestations, in addition to higher complication and surgery rates in this group. Conclusion: Our findings show that although Caucasians still represent the greater fraction of IBD cases, the numbers of Black South Africans affected by this disease have grown. Moreover, in contrast to earlier studies, we found that disease in Black patients is milder compared to White and Indian counterparts. We have been able to illustrate that IBD is in fact a multi-racial disease entity as shown to affect various ethnic groups.
    No preview · Article · Jan 2011 · South African Gastroenterology Review
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Race and socioeconomic status (SES) significantly affect the content and delivery of healthcare for multiple chronic disease states. Inflammatory bowel disease (IBD) is a set of complex, chronic diseases with the potential for significant morbidity if the content or delivery of healthcare is suboptimal. However, the literature related to race, SES, and IBD remains fragmented. METHODS: Using guidelines published by the Centre for Reviews and Dissemination, we performed a systematic review of the world's literature to identify studies related to: 1) IBD, 2) race/ethnicity, 3) SES, 4) healthcare delivery, and 5) healthcare effectiveness. RESULTS: We identified 40 studies that met inclusion criteria. Twenty-four studies (60%) assessed the role of SES and 21 (53%) evaluated race. Topics addressed by these studies included: 1) Utilization of Medical and Surgical Therapy; 2) Adherence to Medical Therapy; 3) Clinical Outcomes; 4) Healthcare Access and Utilization; 5) Disease Perception and Knowledge; and 6) Employment/Insurance. We identified race- and SES-based disparities in the content of medical and surgical healthcare, utilization of inpatient and ambulatory medical care, adherence to medical therapy, and disease perceptions and knowledge. Several studies also identified race- and SES-based disparities in outcomes for IBD, including in-hospital mortality rates and health-related quality of life. CONCLUSIONS: Race- and SES-based disparities in the delivery and effectiveness of healthcare for patients with IBD exist in numerous domains, yet studies remain limited in their scope and breadth. Concerted, prospective, multicenter efforts are needed to address underlying causes for disparities and to identify methods of reducing and eliminating disparities. (Inflamm Bowel Dis 2012;).
    No preview · Article · May 2012 · Inflammatory Bowel Diseases
Show more